Status:
COMPLETED
Transcranial Direct Current Stimulation (tDCS) as a Cognitive Functioning Enhancement Treatment for ADHD Patients Compared to Healthy Controls
Lead Sponsor:
Hebrew University of Jerusalem
Conditions:
Transcranial Direct Current Stimulation
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
This study will examine the possible effects of tDCS (Transcranial Direct Current Stimulation) treatment to the left DLPFC on cognitive functions which were found to be deficient amongst ADHD patients...
Eligibility Criteria
Inclusion
- Participation criteria for healthy participants
- Right hand dominance.
- No psychiatric nor neural diagnosis.
- Participants must be able to comprehend the study's procedure and sign an informed consent.
- Participation criteria for ADHD diagnosed participants
- ADHD diagnosis (according to DSM V).
- Right hand dominance.
- Participants must be able to comprehend the study's procedure and sign an informed consent.
- Participants who regularly use Methylphenidate will be required to avoid the medication for 24 hours prior to study and 12 hours post study.
- \-
Exclusion
- a. Other psychiatric diagnoses (additional to ADHD). b. Drug use (excluding Methylphenidate). c. Neurological disorders. d. Pacemaker, Insulin pump
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT04697316
Start Date
August 1 2021
End Date
June 1 2023
Last Update
March 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hebrew University of Jerusalem
Jerusalem, Israel